leuprolide acetate 22.5 MG Injection
- RxCUI
- 2606516
- RxNorm name
- leuprolide acetate 22.5 MG Injection
- Display name
- leuprolide acetate 22.5 MG Injection
- Full name
- leuprolide acetate 22.5 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LUTRATE DEPOT | LEUPROLIDE ACETATE | Avyxa Pharma, LLC | 3a6d1373-17d9-4289-b62f-d299ffe55831 | 2025-06-03 | Warnings, Adverse reactions | 2606516 |
| LEUPROLIDE ACETATE DEPOT | LEUPROLIDE ACETATE | CIPLA USA INC. | 1563a30b-66e0-445d-ba3e-1ccd5218133f | 2024-08-27 | Warnings, Adverse reactions | 2606516 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1563a30b-66e0-445d-ba3e-1ccd5218133f | leuprolide acetate 22.5 MG Injection | PSN | 5 | These highlights do not include all the information needed to use LEUPROLIDE ACETATE FOR DEPOT SUSPENSION safely and effectively. See full prescribing information for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. Initial U.S. Approval: 2018 | 20240827 |
| 1563a30b-66e0-445d-ba3e-1ccd5218133f | leuprolide acetate 22.5 MG Injection | SCD | 5 | These highlights do not include all the information needed to use LEUPROLIDE ACETATE FOR DEPOT SUSPENSION safely and effectively. See full prescribing information for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. Initial U.S. Approval: 2018 | 20240827 |
| 3a6d1373-17d9-4289-b62f-d299ffe55831 | leuprolide acetate 22.5 MG Injection | PSN | 2 | These highlights do not include all the information needed to use LUTRATE DEPOT safely and effectively. See full prescribing information for LUTRATE DEPOT. LUTRATE ® DEPOT (leuprolide acetate), for depot suspension Initial U.S. Approval: 2018 | 20250603 |
| 3a6d1373-17d9-4289-b62f-d299ffe55831 | leuprolide acetate 22.5 MG Injection | SCD | 2 | These highlights do not include all the information needed to use LUTRATE DEPOT safely and effectively. See full prescribing information for LUTRATE DEPOT. LUTRATE ® DEPOT (leuprolide acetate), for depot suspension Initial U.S. Approval: 2018 | 20250603 |